Tag: anemia
SIGN UP FOR OUR NEWS LETTER


Quick Search

Reset

Preventing Side Effects from Testosterone Inactivating Pharmaceuticals

Fri 1 Oct 2010

By: Mark Scholz, M.D. Prostate Oncology Specialists October 2010 Testosterone inactivating pharmaceuticals (TIP) prolong survival in randomized prospective trials. TIP, when used after surgery in men with lymph node metastasis, decreases mortality seven fold when used immediately rather than being delayed to the time of disease progression.1 TIP administered with radiation reduces prostate cancer mortality.2Read More ›

Preventing and Treating the Side Effects of Testosterone Deprivation Therapy in Men with Prostate Cancer A Guide for Patients and Physicians

Fri 30 Nov 2007

  By Brad Guess PA-C Former PCRI Executive Director Edited from PCRI Insights November, 2007 vol. 10, no.4 In the early 1940s, Drs. Huggins and Hodges discovered that when testosterone was removed by castration, men with advanced metastatic prostate cancer went into remission for 2-3 years.1 They found that prostate cancer was “sensitive” to testosterone;Read More ›

Preventing and Treating the Side Effects of Testosterone Deprivation Therapy in Men with Prostate Cancer A Guide for Patients and Physicians

Thu 1 Nov 2007

By Brad Guess PA-C Former PCRI Executive Director Edited from PCRI Insights November, 2007 vol. 10, no.4 In the early 1940s, Drs. Huggins and Hodges discovered that when testosterone was removed by castration, men with advanced metastatic prostate cancer went into remission for 2-3 years.1 They found that prostate cancer was “sensitive” to testosterone; prostateRead More ›

Laboratory Tests Defined

Tue 31 May 2005

PCRI Insights May, 2005 vol. 8, no. 2 By Mark C. Scholz, MD, Director, Prostate Oncology Specialists, Marina del Rey, CA An important first step in the screening procedure is, of course, the physical examination taken at the first visit of a patient to our practice and scheduled to be repeated each year thereafter. InRead More ›

Anemia Associated With Androgen Deprivation (AAAD)

Sat 1 May 1999

by S. B. Strum, J. E. McDermed, M. C. Scholz, H. Johnson and G. Tisman This article originally appeared as a booklet, last edited May, 1999. An Overview And Description Of This Adverse Effect Commonly Seen In Prostate Cancer Patients Receiving Combination Hormone Blockade ABSTRACT Objectives To describe the incidence, time to onset and extentRead More ›

The Androgen Deprivation Syndrome

Fri 1 Jan 1999

By Stephen B. Strum, MD, Healing Touch Oncology Reprinted from PCRI Insights January 1999, vol. 2, no. 1 A myriad of symptoms typically arises in a PC patient who undergoes androgen deprivation therapy (ADT). Some of these occur acutely and many may improve over time, but can still be quite troublesome if not aggravating forRead More ›